Barrett’s Esophagus Panel: Establishing Individual Patient Risk for Progression to Esophageal Cancer

Understand how TissueCypher® predicts future development of HGD/EAC in patients with BE. Impacts patient-care decisions as demonstrated by case studies.

Sri Komanduri, MD, FASGE, AGAF
Director of Endoscopy
Northwestern University

Rhonda Souza, MD
Co-Director
Baylor Scott & White Health

Vani Khonda, MD
Medical Director
Baylor Scott & White Health

Watch

TissueCypher® Objectively Risk Stratifies Barrett’s Esophagus Patients with Low-Grade Dysplasia*

Pathologic diagnosis is highly variable, even among experts, while TissueCypher® provides objective risk stratification. TissueCypher outperformed community and expert pathologists for sensitivity and detected >50% of NDBE progressors who were down-staged (i.e. missed).

Nicola Frei, Doctor of Medicine
Amsterdam UMC

Slides
Watch

Prediction of Progression in Barrett’s Esophagus Using a Tissue Systems Pathology Test: A Pooled Analysis of International Multicenter Studies*

Addition of TissueCypher® significantly increases the accuracy and power of risk prediction providing for personalized management of BE patients.

Prasad G. Iyer, MD, MS, FASGE, FACG
Gastroenterologist, Mayo Clinic

Slides
Watch

Risk Stratification and Management of Dysplastic Barrett’s Esophagus*

Risk stratification is important in managing BE patients and biomarker assays such as TissueCypher® are “ready for Prime Time” in identifying patients at high risk for progression.

Marcia Canto, MD MHS
Johns Hopkins University
Division of Gatroenterology

Slides
Watch

* All content is derived from presentations and similar offerings made at Digestive Disease Week® 2021 and is presented with permission of DDW, LLC.

Barrett’s Esophagus Panel: Predicting Progression in Barrett’s Esophagus Recent Advances Webinar

A panel discussion on the clinical challenges associated with predicting progression to esophageal adenocarcinoma in patients with Barrett’s esophagus.

Sri Komanduri, MD, FASGE, AGAF
Director of Endoscopy
Northwestern University

Prasad G. Iyer, MD, MS, FASGE, FACG
Gastroenterologist, Mayo Clinic

David Diehl, MD, FACP, FASGE
Director of Interventional Endoscopy
Geisinger Health System

Watch